2008The Chinese Journal of Clinical PharmacologyRequires access

Pharmacokinetics of ribavirin tablets in healthy volunteers

Jinguang Huang

Open publisher page 0 citations

Abstract

Objective To evaluate the safety and pharmacokinetic parameters of a domestic ribavirin tablets in Chinese healthy male volunteers after administered 300 mg oral dosage. Methods Twenty healthy Chinese volunteers were given a single oral dose domestic ribavirin tablet. The concentration of ribavirin in blood plasma was measured by an validated LC-MS/MS method and were assessed with non-compartment model to obtain the pharmacokinetic parameters.Results The pharmacokinetic parameters of ribavirin tablets for orally administered 300 mg dosage were as follows: AUC0-t was(5584.91±1659.34)ng.h.mL-1; AUC0-∞ was(7166.33±2224.28)ng.h.mL-1;Cmax was(442.60±148.97)ng.mL-1;tmax was(1.40±1.20)h;t1/2 was(22.93±6.38)h;Ke was (0.03±0.01) h-1;Vd was (1484.37±491.50);CL was (45.67±13.90) L.h-1.Conclusion The results showed that there was no significant difference in pharmacokinetics compared with the reference which had reported 2-5 .

About this research paper

What this paper is about

Objective To evaluate the safety and pharmacokinetic parameters of a domestic ribavirin tablets in Chinese healthy male volunteers after administered 300 mg oral dosage. Methods Twenty healthy Chinese volunteers were given a single oral dose domestic ribavirin tablet. The concentration of ribavirin in blood plasma was measured by an validated LC-MS/MS method and were assessed with non-compartment model to obtain the pharmacokinetic parameters.Results The pharmacokinetic parameters of ribavirin tablets for orally administered 300 mg dosage were as follows: AUC0-t was(5584.91±1659.34)ng.h.mL-1; AUC0-∞ was(7166.33±2224.28)ng.h.mL-1;Cmax was(442.60±148.97)ng.mL-1;tmax was(1.40±1.20)h;t1/2 was(22.93±6.38)h;Ke was (0.03±0.01) h-1;Vd was (1484.37±491.50);CL was (45.67±13.90) L.h-1.Conclusion The results showed that there was no significant difference in pharmacokinetics compared with the reference which had reported 2-5 .

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the safety and pharmacokinetic parameters of a domestic ribavirin tablets in Chinese healthy male volunteers after administered 300 mg oral dosage. Methods Twenty healthy Chinese volunteers were given a single oral dose domestic ribavirin tablet. The concentration of ribavirin in blood plasma was measured by an validated LC-MS/MS method and were assessed with non-compartment model to obtain the pharmacokinetic parameters.Results The pharmacokinetic parameters of ribavirin tablets for orally administered 300 mg dosage were as follows: AUC0-t was(5584.91±1659.34)ng.h.mL-1; AUC0-∞ was(7166.33±2224.28)ng.h.mL-1;Cmax was(442.60±148.97)ng.mL-1;tmax was(1.40±1.20)h;t1/2 was(22.93±6.38)h;Ke was (0.03±0.01) h-1;Vd was (1484.37±491.50);CL was (45.67±13.90) L.h-1.Conclusion The results showed that there was no significant difference in pharmacokinetics compared with the reference which had reported 2-5 .

Key concepts: Pharmacokinetics, Ribavirin, Cmax, Medicine, Pharmacology, Plasma concentration, Virology, Virus

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of ribavirin tablets in healthy volunteers — Research Paper | ScholarLens